NewsBenzingaBTIG重申对Nektar Therapeutics的买入评级，维持178美元的目标股价 BTIG重申对Nektar Therapeutics的买入评级，维持178美元的目标股价 Benzinga 2026.09.25 14:31 (GMT+0) Open on Benzinga Other news What Is Going on With Western Digital Stock on Friday? Jefferies Initiates Coverage On Comstock Resources with Hold Rating, Announces Price Target of $14 Why Is Atlas Energy Stock Gaining Friday? Petrobras Receives R$2.3B As New Installment Under Economic Subsidy For Diesel Commercialization Evercore ISI Group Maintains Outperform on PulteGroup, Lowers Price Target to $154 Jefferies Downgrades Gulfport Energy to Hold, Lowers Price Target to $180
